MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication
an InvestmentWires' Publication
|
|
MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication |
|
Monday, January 13, 2014 Barron's Ponders the Tactics of Three Fido Funds Barron's writer Brendan Conway analyzes three Fidelity funds and their tactics within regards to the the stocks of Intercept Pharmaceuticals, which surged 582% in 2013. The funds analyzed were the Fidelity Select Biotechnology, Fidelity Select Healthcare, and the Fidelity Contrafund. Printed from: MFWire.com/story.asp?s=47309 Copyright 2014, InvestmentWires, Inc. All Rights Reserved |